NewInsight: The AI sell-off compared to well-known stock market crashes

Labcorp LH

Labcorp is the 319th largest S&P 500 company by market cap, worth $29.8 billion. Its board has 11 directors, 10 of them independent. 10 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 12.1% of the company.

Chair and CEO
Adam H. Schechter
Sector
Health CareHealth Care Services
Headquarters
Burlington, North Carolina
Founded
1978
Market cap
$29.8B
319th largest, 6 Nov 2026 close
Revenue
$14.0B
Fiscal year 2025
Price to sales
2.1
Market cap over revenue
Employees
71,000
10-K, 31 Dec 2025
Per employee
$419K
Market cap over employees
Connections
7
Companies sharing people

Financials

Latest quarter

Q3 2026 figures from Labcorp's earnings release.

Filed 28 Oct 2026

Revenue
$3.8B
Up 6.9% year over year
Net income
$263M
Up 0.7% year over year
Diluted EPS
$3.22
Up 3.3% year over year
Operating income
$402M
Up 1.4% year over year

Reported figures

Figures from the release, against the same period a year earlier.

FigureValueYear earlierChange
Revenue$3.8B$3.6B+6.9%
Diluted EPS$3.22$3.12+3.3%
Adjusted EPS$4.78$4.18+15%
Operating Income$402M$397M+1.4%
Operating Income as % of Revenue10.6%11.1%-0.5 pts
Adjusted Operating Income$570M$513M+11%
Adjusted Operating Income as % of Revenue15%14.4%+0.6 pts
Net Earnings Attributable to Labcorp Holdings Inc.$263M$261M+0.7%
Free Cash Flow$412M$281M+47%

Financial history

Twelve months to 30 Sep 2026, from Labcorp's quarterly filings.

Quarters since Dec 2021

Revenue
$14.6B
Up 6.0% on the year before
Net income
$1.0B
6.9% of revenue
Free cash flow
$1.3B
Operating cash flow less capital spending
P/E
29.6
Market cap over net income

Quarterly results

Each quarter's revenue, net income and free cash flow.

Dec 2021 to Sep 2026

$0$2B$4B$6B202120222023202420252026$3.8B

Per employee

Twelve months to 30 Sep 2026, over 71,000 employees in Labcorp's latest 10-K.

Revenue
$206K
Operating profit
$21K
10.3% of revenue
Net income
$14K
6.9% of revenue

Labcorp's market cap since December 2008

Marked weeks are changes in the share count, such as a merger, not market moves.

Weekly, up to 6 Nov 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$29.8B

Board and leadership

Board and officers

7 people here also hold roles at other S&P 500 companies.

Board from the proxy filed 10 Apr 2026; officers filed up to 30 Sep 2026

NameTitleSinceIndependentCommitteesAge
Directors (11)
Adam H. SchechterChair; President & CEONot independent · since 2013Also at DaVitaChair; President & CEO2013No61
Kerrii B. AndersonDirectorIndependent · since 2006 · Audit, Nominating and Corporate GovernanceFormer Chief Executive Officer, Wendy's International, Inc.Also at Sherwin-WilliamsOther boards: Worthington Enterprises and Abercrombie & Fitch Co.Director2006YesAudit, Nominating and Corporate Governance68
Carulla Victor BultoDirectorIndependent · since 2025 · AuditPresident, Novartis USDirector2025YesAudit47
Jeffrey A. DavisDirectorIndependent · since 2019 · Audit (chair), Quality and ComplianceFormer Chief Financial Officer, Dollar Tree, Inc.Also at FedEx FreightDirector2019YesAudit (chair), Quality and Compliance62
Kirsten Marie KliphouseDirectorIndependent · since 2022 · AuditFormer President, Google Cloud AmericasAlso at Global PaymentsDirector2022YesAudit59
Garheng KongLead Independent DirectorIndependent · since 2013 · Compensation and Human Capital, Nominating and Corporate Governance (chair)Managing Partner, HealthQuest CapitalOther boards: Smith & Nephew plc, IKS Health, Lunit and Xeris Biopharma HoldingsLead Independent Director2013YesCompensation and Human Capital, Nominating and Corporate Governance (chair)50
Peter M. NeupertDirectorIndependent · since 2013 · Nominating and Corporate GovernanceFormer Operating Partner, Health Evolution PartnersOther boards: Adaptive Biotechnologies Corporation and Fortrea HoldingsDirector2013YesNominating and Corporate Governance70
Richelle P. ParhamDirectorIndependent · since 2016 · Compensation and Human Capital (chair), Nominating and Corporate GovernanceFormer President of Global E-Commerce and Business Development, Universal Music GroupAlso at Best BuyDirector2016YesCompensation and Human Capital (chair), Nominating and Corporate Governance58
Paul RothmanDirectorIndependent · since 2023 · Compensation and Human Capital, Quality and Compliance (chair)Former Dean of the Medical Faculty for Johns Hopkins University School of Medicine and Former Chief Executive Officer of Johns Hopkins MedicineAlso at Merck & Co.Director2023YesCompensation and Human Capital, Quality and Compliance (chair)68
John H. SampsonDirectorIndependent · since 2026 · Quality and ComplianceVice Chancellor and Dean, University of Colorado Anschutz School of Medicine, President of CU MedicineDirector2026YesQuality and Compliance59
Kathryn E. WengelDirectorIndependent · since 2021 · Compensation and Human Capital, Quality and ComplianceExecutive Vice President, Chief Technical Operations & Risk Officer, Executive Committee Member, Johnson & JohnsonAlso at Johnson & JohnsonDirector2021YesCompensation and Human Capital, Quality and Compliance60
Officers (10)
Julia Aijun WangChief Financial Officer, EVPLast filed 13 Feb 2026Chief Financial Officer, EVP
Brian J. CaveneyEVP, Pres of BLS, CMO & CSOLast filed 3 Sep 2026EVP, Pres of BLS, CMO & CSO
Anita Z. GrahamEVP, CHROLast filed 30 Mar 2026EVP, CHRO
Kathryn W. KyleEVP, Chief Legal OfficerLast filed 6 Jul 2026EVP, Chief Legal Officer
Jonathan C. MeltzerEVP, COOLast filed 3 Sep 2026EVP, COO
Akinbolade OyegunwaEVP, CIO & CTOLast filed 3 Sep 2026EVP, CIO & CTO
Amy B. SummyEVP, Chief Marketing OfficerLast filed 6 Aug 2026EVP, Chief Marketing Officer
Sandra D. van der VaartEVP, Corporate AffairsLast filed 30 Mar 2026EVP, Corporate Affairs
Bryan T. VaughnEVP and President, DiagnosticsLast filed 3 Sep 2026EVP and President, Diagnostics
Peter J. WilkinsonSVP, Chief Accounting OfficerLast filed 5 Aug 2026SVP, Chief Accounting Officer

Companies that share people with Labcorp

Each person's title here, then at the other company.

  • Best Buy BBY
    • Richelle P. Parham: Director here, Director there
  • DaVita DVA
    • Adam H. Schechter: President & CEO here, Director there
  • FedEx Freight FDXF
    • Jeffrey A. Davis: Director here, Director there
  • Global Payments GPN
    • Kirsten Marie Kliphouse: Director here, Director there
  • Johnson & Johnson JNJ
    • Kathryn E. Wengel: Director here, EVP, Chief TO and Risk Officer there
  • Merck & Co. MRK
    • Paul Rothman: Director here, Director there
  • Sherwin-Williams SHW
    • Kerrii B. Anderson: Director here, Director there

Owners and trading

Largest institutional holders

Each fund group's share of Labcorp. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 34.5% of Labcorp.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 6 Nov 2025 to 6 Nov 2026

Directors and officers sold $12.4 million of stock in 21 sales and made no open-market purchases in the 12 months to 6 Nov 2026.

DatePersonTitleTypeSharesValue
3 Nov 2026SaleBryan T. VaughnEVP and President, DiagnosticsEVP and President, DiagnosticsSale306$108K
30 Oct 2026SaleRichelle P. ParhamDirectorDirectorSale1,078$389K
17 Aug 2026SaleKerrii B. AndersonDirectorDirectorSale3,000$954K
11 Aug 2026SaleAdam H. SchechterPresident & CEOPresident & CEOSale4,669$1.5M
4 Aug 2026SaleAmy B. SummyEVP, Chief Marketing OfficerEVP, Chief Marketing OfficerSale924$283K
3 Aug 2026SalePeter J. WilkinsonSVP, Chief Accounting OfficerSVP, Chief Accounting OfficerSale1,420$439K
2 Jul 2026SaleBryan T. VaughnEVP and President, DiagnosticsEVP and President, DiagnosticsSale234$67K
2 Jul 2026SaleKathryn W. KyleEVP, Chief Legal OfficerEVP, Chief Legal OfficerSale92$26K
8 Jun 2026SaleKathryn W. KyleEVP, Chief Legal OfficerEVP, Chief Legal OfficerSale762$201K
11 May 2026SaleAdam H. SchechterPresident & CEOPresident & CEOSale5,903$1.5M

Showing 10 of 21 trades

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 27 Oct 2023 to 27 Oct 2026

9 people disclosed 22 purchases and 17 sales of Labcorp stock since October 2023.

DateMember or officialTypeAmount
4 Sep 2026Rohit Khanna (House, D-CA)House, D-CA · BoughtPurchase$1,001 to $15,000$1K to $15K
25 Aug 2026April McClain Delaney (House, D-MD)House, D-MD · SoldSale$100,001 to $250,000$100K to $250K
7 Aug 2026April McClain Delaney (House, D-MD)House, D-MD · SoldSale$1,001 to $15,000$1K to $15K
6 Aug 2026April McClain Delaney (House, D-MD)House, D-MD · SoldSale$1,001 to $15,000$1K to $15K
5 Aug 2026April McClain Delaney (House, D-MD)House, D-MD · SoldSale$1,001 to $15,000$1K to $15K
11 May 2026Donald J Trump (President)President · BoughtPurchase$100,001 to $250,000$100K to $250K
10 Apr 2026Donald J Trump (President)President · SoldSale$15,001 to $50,000$15K to $50K
27 Mar 2026Alan Armstrong (Senate, R-OK)Senate, R-OK · BoughtPurchase$1,001 to $15,000$1K to $15K
19 Feb 2026Tony Wied (House, R-WI)House, R-WI · BoughtPurchase$15,001 to $50,000$15K to $50K
11 Feb 2026April McClain Delaney (House, D-MD)House, D-MD · BoughtPurchase$1,001 to $15,000$1K to $15K

Showing 10 of 39 trades

Workforce and hiring

Workforce

Headcount at 31 Dec 2025

Employees
71,000

Employees, last 10 fiscal years

Down 1.9% in five years, from 72,400 in 2020 to 71,000 in 2025.

During 2025, the Company’s nearly 71,000 employees served clients in approximately 100 countries and performed more than 750 million tests for patients around the world.
Labcorp Form 10-K

Open roles

Jobs listed on Labcorp's careers site, each counted once.

Daily, up to 3 Nov 2026

Open roles
1,776
On 3 Nov 2026
Change
-65
Down 3.5% since 27 Oct 2026
Top function
Customer & Retail
51% of open roles
Remote
1%
Fully remote roles

Open roles in detail

27 Oct 2026 to 3 Nov 2026

27 Oct3 Nov1,776

WARN layoff notices

Notices filed under Labcorp's own name or a subsidiary's listed in its 10-K.

Notices from 7 Nov 2023 to 7 Nov 2026

Labcorp filed 4 notices covering 272 workers since November 2023.

NoticePlaceWorkersEffective
5 Mar 2025Los Angeles, CA7316 May 2025
16 Sep 2024Melbourne, FL6522 Nov 2024
16 Sep 2024Houston, TX5322 Nov 2024
13 May 2024CA8119 Jul 2024

Timeline

Leadership changes, layoffs and insider sales

7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025

4 departures and 5 appointments of directors and officers, WARN layoff notices on 1 day and 5 large insider sales in the last two years.

Left the company or board 4Appointed 5WARN layoff notices 1Large insider sales 5Jan 2025AprJulOctJan 2026AprJulOct

Insider sales of $1 million or more, and the largest tenth of Labcorp's insider sales.

Events, newest first

Showing 8 of 15 events